Question: is filgrastim approved in canada?
Answer: Apotex's first biosimilar, Grastofil (filgrastim), was approved by Health Canada in December 2015 for the treatment of neutropenia in adults and children receiving chemotherapy [1]. Lapelga is also currently under the US Food and Drug Administration review [2].